Home Newsfeeds Morgan Stanley Maintains Overweight on Agree Realty, Raises Price Target to $77

Morgan Stanley Maintains Overweight on Agree Realty, Raises Price Target to $77

Morgan Stanley analyst Ronald Kamdem maintains Agree Realty (NYSE:ADC) with a Overweight and raises the price target from $75 to $77.

byBenzinga Newsdesk

July 12, 2022

1 minute read

Morgan Stanley analyst Ronald Kamdem maintains Agree Realty (NYSE:ADC) with a Overweight and raises the price target from $75 to $77.

Here’s How Much $1000 Invested In West Pharmaceutical Servs 5 Years Ago Would Be Worth Today

By Benzinga Insights

December 7, 2:00 PM

West Pharmaceutical Servs (NYSE:WST) has outperformed the market over the past 5 years by 14.35% on an annualized…

WST

This Stock Is ‘Way Too Expensive,’ Cramer Says: ‘I’m Sorry, I Can’t Endorse It’

By Lisa Levin

September 29, 10:07 AM

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Rada Electronic Industries Ltd (NASDAQ: RADA) is "way too expensive." He added, "I’m sorry, I can’t endorse it."

ENVX

Encompass Health Q3 EPS $0.67 Beats $0.64 Estimate, Sales $1.09B Beat $1.07B Estimate

By Benzinga Newsdesk

October 26, 5:33 PM

Encompass Health (NYSE:EHC) reported quarterly earnings of $0.67 per share which beat the analyst consensus estimate of $0.64 by 4.69 percent. This is a 34.95 percent decrease over earnings of $1.03 per share from the

EHC